Beth Israel Deaconess Medical Center - 330 Brookline Ave — Boston, Massachusetts

Beth Israel Deaconess Medical Center - 330 Brookline Ave is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Medical Center - 330 Brookline Ave has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Primary Biliary Cirrhosis, Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC).

Sponsors: Gilead Sciences, Takeda.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Medical Center - 330 Brookline Ave?

Beth Israel Deaconess Medical Center - 330 Brookline Ave has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Medical Center - 330 Brookline Ave conducted?

Beth Israel Deaconess Medical Center - 330 Brookline Ave has 2 clinical trials on record, with 2 currently active. Their work covers Primary Biliary Cirrhosis, Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC).

Is Beth Israel Deaconess Medical Center - 330 Brookline Ave accredited by Crixeo Health?

Beth Israel Deaconess Medical Center - 330 Brookline Ave has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Medical Center - 330 Brookline Ave?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.